Nurix Therapeutics NRIX
NASDAQ NRIX
$16.32 +0.44 (+2.77%)
As of: Nov 11, 2026 · 3:59 PM EST

Nurix Therapeutics (NRIX) Other Non-Current Assets (2019 - 2026)

Updated

Nurix Therapeutics' Other Assets was $8.74 million in fiscal Q3 2026 (quarter ended Aug 31, 2026), up 802.5% from $968,000 a year earlier but down 2.3% from the prior quarter.

Analysis

Nurix Therapeutics (NRIX) Other Non-Current Assets (2019 - 2026) Analysis & Trends

At the end of FY2025 (ended Nov 30, 2025), Other Assets at Nurix Therapeutics came in at $8.31 million, up 104.7% from FY2024.

  • Other Assets shows a five-year compound annual growth rate of 85.6% (FY2020 to FY2025).
  • In earlier fiscal years, Other Assets was $4.06 million in FY2024 (+350.6%), $901,000 in FY2023 (unchanged), $901,000 in FY2022 (-71.2%) and $3.13 million in FY2021 (+731.0%).
  • Quarterly Other Assets has moved between $901,000 (fiscal Q1 2022) and $8.95 million (fiscal Q2 2026) over five years.
  • Compared with a year earlier, Other Assets has increased for five straight quarters, with growth averaging 373.5% over the last eight quarters.
  • The best year-over-year quarter for Other Assets over five years was fiscal Q2 2026 (growth of 892.8%); the worst was fiscal Q3 2022 (a decline of 74.8%).
  • Per Business Quant data, NRIX's Other Assets in the three fiscal quarters before Q3 2026 was $8.95 million (Q2 2026), $8.38 million (Q1 2026) and $8.31 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 7.70 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 15.10 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.42 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 19.90 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 700.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 14.60 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 4.90 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 10.02 Bn
10 Nurix Therapeutics 1.73 Bn -891.35 Mn - 8.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2026 8.74 Mn
May 31, 2026 8.95 Mn
Feb 28, 2026 8.38 Mn
Nov 30, 2025 8.31 Mn
Aug 31, 2025 968,000.00
May 31, 2025 901,000.00
Feb 28, 2025 901,000.00
Nov 30, 2024 4.06 Mn
Aug 31, 2024 901,000.00
May 31, 2024 901,000.00
Feb 29, 2024 901,000.00
Nov 30, 2023 901,000.00
Aug 31, 2023 901,000.00
May 31, 2023 901,000.00
Feb 28, 2023 901,000.00
Nov 30, 2022 901,000.00
Aug 31, 2022 901,000.00
May 31, 2022 901,000.00
Feb 28, 2022 901,000.00
Nov 30, 2021 3.13 Mn
API Access

Nurix Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=NRIX&period=max&api_key=YOUR_API_KEY